Exploring Harmala Alkaloids as Novel Antimalarial Agents against Plasmodium falciparum through Bioinformatics Approaches

Kaushik Zaman Dipto,Raiyan Shariar,Chinmoy Kumar Saha,Abir Huzaifa,Tanjin Barketullah Robin,Rajesh B. Patil,Md. Tamzidul Alam,Md. Irfan Habib Rafi,Ashraf Zaman Faruk,Abu Tayab Moin,Kazi Md. Ali Zinnah,Md. Hasanuzzaman,Tofazzal Islam

DOI: https://doi.org/10.1101/2024.07.17.603828

2024-07-18

Abstract:Malaria, caused by the Plasmodium falciparum, remains a significant global health challenge, with Plasmodium falciparum accounting for approximately 50% of cases and posing a considerable threat. Despite advances in control measures, malaria continues to cause an estimated one million deaths annually. The complex lifecycle of P. falciparum, involving both vertebrate hosts and Anopheles mosquitoes, complicates eradication efforts. The parasite's resistance to existing antimalarial drugs, along with medication toxicity, necessitates innovative therapeutic approaches. Recent research has revealed that harmine, an alkaloid produced by an endophytic gut bacterium of Anopheles mosquitoes, can impede the transmission of the malarial parasite to humans by inhibiting a crucial life stage. This study investigates harmala alkaloids, sourced from plants and bacteria such as Peganum harmala, as potential alternatives to conventional antimalarial drugs. Notably, harmine and harmaline have shown promising antimalarial activity by inhibiting the essential enzyme protein kinase 4 (PK4), which is vital for the parasite's survival. These compounds exhibit lower toxicity, effectively inhibiting both the blood stage growth and transmission of the parasite. Using in silico methodologies, including ADME analysis, molecular docking, MD simulation, and toxicity analysis, this study identifies harmala alkaloids as potential inhibitors against crucial P. falciparum proteins. Targeting proteins essential for the parasite's survival, similar to established drugs like pfCRT protein, lays the foundation for developing effective antimalarial treatments. The comprehensive screening of harmala alkaloid molecules opens avenues for the pharmaceutical industry to tackle challenges related to drug resistance and toxicity, offering a promising route for the biorational management of malaria.

Bioinformatics

What problem does this paper attempt to address?

The problems that this paper attempts to solve are drug resistance and toxicity in malaria treatment. Specifically, the paper focuses on how to explore the possibility of Harmala alkaloids as new antimalarial drugs against Plasmodium falciparum through bioinformatics methods. Plasmodium falciparum is one of the main pathogens causing malaria, resulting in approximately 1 million deaths each year. And due to its complex life cycle and resistance to existing antimalarial drugs, malaria prevention and treatment face huge challenges. Therefore, the research aims to discover new antimalarial compounds, especially those with lower toxicity, to replace existing antimalarial drugs, thus effectively dealing with the treatment difficulties of malaria. The paper mentions that Harmala alkaloids such as Harmine and Harmaline show the ability to inhibit protein kinase 4 (PK4), a key enzyme necessary for the survival of Plasmodium falciparum, indicating that they may be effective antimalarial drug candidates. In addition, these compounds also show lower toxicity and effective inhibition of the growth and transmission of the parasite in the blood stage. Through a series of bioinformatics methods such as molecular docking, molecular dynamics simulation, ADME analysis and toxicity analysis, the researchers systematically screened the applicability of Harmala alkaloids as potential antimalarial drugs.

Exploring Harmala Alkaloids as Novel Antimalarial Agents against Plasmodium falciparum through Bioinformatics Approaches

Structure-Based Virtual Screening, Insilico Docking, ADME Prediction, and Molecular Dynamics Studies for Identification of Potential NMT Inhibitors Against Malaria

An in silico quest for next-generation antimalarial drugs by targeting Plasmodium falciparum hexose transporter protein: a multi-pronged approach

Antimalarial drug discovery against malaria parasites through haplopine modification: An advanced computational approach

Identification of novel Plasmodium falciparum dihydroorotate dehydrogenase inhibitors for malaria using in silico studies

Unveiling Potential Repurposed Drug Candidates for Plasmodium falciparum through In Silico Evaluation: A Synergy of Structure-based Approaches, Structure Prediction, and Molecular Dynamics Simulations

Natural Products for Treatment of Plasmodium Falciparum Malaria: an Integrated Computational Approach.

Discovery of dual-target natural antimalarial agents against DHODH and PMT of Plasmodium falciparum: pharmacophore modelling, molecular docking, quantum mechanics, and molecular dynamics simulations

In silico Comparison of Novel Proteins from Plasmodium Falciparum as Candidate Drug Targets against Malaria

Discovery of Potential Prolyl-tRNA Synthetase Allosteric Inhibitor Through Virtual Screening and In Vitro Assay against Plasmodium falciparum

Structural Exploration of the PfBLM Helicase-ATP Binding Domain and Its Implications in the Quest for Antimalarial Therapies

Bioactive compounds as therapeutic proposals against Plasmodium falciparum : A systematic review

In Silico Screening for Identification of Novel Anti-malarial Inhibitors by Molecular Docking, Pharmacophore Modeling and Virtual Screening.

Hybrid Peptide-Alkoxyamine Drugs: A Strategy for the Development of a New Family of Antiplasmodial Drugs

Search for novel Plasmodium falciparum PfATP4 inhibitors from the MMV Pandemic Response Box through a virtual screening approach

Towards development of new antimalarial compounds through in silico and in vitro assays

Rational-Based Discovery of Novel β-Carboline Derivatives as Potential Antimalarials: From In Silico Identification of Novel Targets to Inhibition of Experimental Cerebral Malaria

Alkaloids from Plants with Antimalarial Activity: A Review of Recent Studies

In silico study, synthesis and antimalarial evaluation of hybrid pyridine substituted pyrazole 1,3,5-triazine derivatives

DeepMalaria: Artificial Intelligence Driven Discovery of Potent Antiplasmodials

Multiple-targets Directed Screening of Flavonoid Compounds from Citrus Species to find out Antimalarial Lead with Predicted Mode of Action: An In Silico and Whole Cell-based In vitro Approach